Uric acid level and risk of symptomatic intracranial haemorrhage in ischaemic stroke treated with endovascular treatment.

Abstract

There are limited data on the association between uric acid (UA) and symptomatic intracranial haemorrhage (SICH) in patients who have undergone mechanical thrombectomy [endovascular treatment (EVT)]. In the present study, we aimed to investigate the role of serum UA level in SICH after EVT in a real-world practice. Patients were selected from the Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke (ACTUAL) registry. SICH was identified using the Heidelberg Bleeding Classification. Multivariable logistic regression analysis was performed to explore the relationship between serum UA and SICH. Among 611 enrolled patients, 90 (14.7%) were diagnosed with SICH within 72h after EVT. Patients with SICH had a significantly higher level of serum UA (median, 341.0 vs. 302.0μmol/L; P=0.003) than those without SICH. Univariate logistic regression analysis indicated that patients with UA levels in the fourth quartile, compared with the first quartile, were more likely to have SICH (odds ratio, 2.846; 95% confidence intervals, 1.429-6.003; P=0.003). The association remained significant after multivariable adjustment for potential confounders. Furthermore, the multiple-adjusted spline regression model showed an inverted U-shaped association between UA and SICH (P=0.047 for non-linearity). Our study indicated that increased serum UA level was independently associated with SICH after EVT in acute ischaemic stroke.